AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval
BioSpace
by
13h ago
AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval 12/1/2023 ..read more
Visit website
Astellas Touts Phase III Data for Menopause Drug, Eyes European Reimbursement
BioSpace
by
13h ago
Astellas Touts Phase III Data for Menopause Drug, Eyes European Reimbursement 12/1/2023 ..read more
Visit website
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
BioSpace
by
13h ago
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status 12/1/2023 ..read more
Visit website
AstraZeneca Axes Two Phase III Hyperkalemia Trials for Lokelma
BioSpace
by
13h ago
AstraZeneca Axes Two Phase III Hyperkalemia Trials for Lokelma 12/1/2023 ..read more
Visit website
Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News
BioSpace
by
13h ago
Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News 12/1/2023 ..read more
Visit website
Pfizer Nixes Twice-Daily Oral GLP-1 Candidate After High Rates of Side Effects
BioSpace
by
13h ago
Pfizer Nixes Twice-Daily Oral GLP-1 Candidate After High Rates of Side Effects 12/1/2023 ..read more
Visit website
Deals, Dupixent and GLP-1 drug shortages
BioSpace
by
2d ago
Deals, Dupixent and GLP-1 drug shortages 11/29/2023 ..read more
Visit website
Real-World Data Shows Lilly’s Tirzepatide Beats Novo’s Semaglutide at Weight Loss
BioSpace
by
2d ago
Real-World Data Shows Lilly’s Tirzepatide Beats Novo’s Semaglutide at Weight Loss 11/29/2023 ..read more
Visit website
Top Biopharma Companies Hiring in California Right Now
BioSpace
by
2d ago
Top Biopharma Companies Hiring in California Right Now 11/30/2023 ..read more
Visit website
Opinion: How to Vet Your Next Company
BioSpace
by
2d ago
Opinion: How to Vet Your Next Company 11/30/2023 ..read more
Visit website

Follow BioSpace on FeedSpot

Continue with Google
Continue with Apple
OR